These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36150821)

  • 41. Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection.
    Lee AY; Ewing AD; Ellrott K; Hu Y; Houlahan KE; Bare JC; Espiritu SMG; Huang V; Dang K; Chong Z; Caloian C; Yamaguchi TN; ; Kellen MR; Chen K; Norman TC; Friend SH; Guinney J; Stolovitzky G; Haussler D; Margolin AA; Stuart JM; Boutros PC
    Genome Biol; 2018 Nov; 19(1):188. PubMed ID: 30400818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.
    Koeppel F; Muller E; Harlé A; Guien C; Sujobert P; Trabelsi Grati O; Kosmider O; Miguet L; Mauvieux L; Cayre A; Salgado D; Preudhomme C; Karayan-Tapon L; Tachon G; Coulet F; Lespagnol A; Beroud C; Leroy K; Rouleau E; Soubeyran I
    Eur J Cancer; 2021 Dec; 159():1-15. PubMed ID: 34700215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
    Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
    BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
    Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
    Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VarBen: Generating in Silico Reference Data Sets for Clinical Next-Generation Sequencing Bioinformatics Pipeline Evaluation.
    Li Z; Fang S; Zhang R; Yu L; Zhang J; Bu D; Sun L; Zhao Y; Li J
    J Mol Diagn; 2021 Mar; 23(3):285-299. PubMed ID: 33346148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Next-Generation Sequencing Somatic and Germline Assay Troubleshooting Guide Derived From Proficiency Testing Data.
    Nardi V; Tsuchiya KD; Kim AS; Bean LJH; Halley JG; Long TA; Szelinger S; Vasalos P; Thorson JA; Moyer AM; Moncur JT
    Arch Pathol Lab Med; 2022 Apr; 146(4):451-461. PubMed ID: 34424952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Implementation and Validation of Automated Human Genome Variation Society (HGVS) Nomenclature System for Next-Generation Sequencing-Based Assays for Cancer.
    Callenberg KM; Santana-Santos L; Chen L; Ernst WL; De Moura MB; Nikiforov YE; Nikiforova MN; Roy S
    J Mol Diagn; 2018 Sep; 20(5):628-634. PubMed ID: 29936258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of Pathogenicity of
    Brown A; Zamanpoor M; Love DR; Prosser DO
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e324-e334. PubMed ID: 31897316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines.
    Li Q; Wang K
    Am J Hum Genet; 2017 Feb; 100(2):267-280. PubMed ID: 28132688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients.
    Feliubadaló L; Moles-Fernández A; Santamariña-Pena M; Sánchez AT; López-Novo A; Porras LM; Blanco A; Capellá G; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; de la Cruz X; Diez O; Ruiz-Ponte C; Gutiérrez-Enríquez S; Vega A; Lázaro C
    Clin Chem; 2021 Mar; 67(3):518-533. PubMed ID: 33280026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Bioinformatics in Precise Diagnosis of Mitochondrial Disease.
    Shen L; McCormick EM; Muraresku CC; Falk MJ; Gai X
    Clin Lab Med; 2020 Jun; 40(2):149-161. PubMed ID: 32439066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variant classification in precision oncology.
    Leichsenring J; Horak P; Kreutzfeldt S; Heining C; Christopoulos P; Volckmar AL; Neumann O; Kirchner M; Ploeger C; Budczies J; Heilig CE; Hutter B; Fröhlich M; Uhrig S; Kazdal D; Allgäuer M; Harms A; Rempel E; Lehmann U; Thomas M; Pfarr N; Azoitei N; Bonzheim I; Marienfeld R; Möller P; Werner M; Fend F; Boerries M; von Bubnoff N; Lassmann S; Longerich T; Bitzer M; Seufferlein T; Malek N; Weichert W; Schirmacher P; Penzel R; Endris V; Brors B; Klauschen F; Glimm H; Fröhling S; Stenzinger A
    Int J Cancer; 2019 Dec; 145(11):2996-3010. PubMed ID: 31008532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.
    Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB
    Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Next Generation of Molecular Pathology is Here: Validation of Next-Generation Sequencing Technology for Clinical Molecular Testing Across Multiple Different Disciplines.
    Weck KE
    Arch Pathol Lab Med; 2017 Jun; 141(6):749-750. PubMed ID: 28557596
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.
    Konnick EQ; Pritchard CC
    Genome Med; 2016 Oct; 8(1):100. PubMed ID: 27716394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
    McNulty SN; Parikh BA; Duncavage EJ; Heusel JW; Pfeifer JD
    J Mol Diagn; 2019 Sep; 21(5):903-912. PubMed ID: 31251990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
    Lockwood CM; Borsu L; Cankovic M; Earle JSL; Gocke CD; Hameed M; Jordan D; Lopategui JR; Pullambhatla M; Reuther J; Rumilla KM; Tafe LJ; Temple-Smolkin RL; Terraf P; Tsimberidou AM
    J Mol Diagn; 2023 Dec; 25(12):876-897. PubMed ID: 37806433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.